Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 56

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 56
---
200,000 |     | ND                                |
| John F. Milligan, Ph.D.                                      |     |                        200,000 |     | ND                                |
| Marshall Mohr                                                |     |                        200,000 |     | ND                                |
| Kathy Ordoñez                                                |     |                        200,000 |     | ND                                |
| Lucy Shapiro, Ph.D.                                          |     |                        200,000 |     | ND                                |
| Christopher M. Smith(2)                                      |     |                        100,000 |     | ND                                |
| Hannah A. Valantine, M.D.                                    |     |                        200,000 |     | ND                                |
| All current non-employee directors, as a group (8) people(2) |     |                      1,500,000 |     | ND                                |

(1) Abbreviation: ND, not yet determinable. As described above, the number of Shares will be calculated based on the grant date fair value of the award and subject to any aggregate share limitation for each non-employee director. Pursuant to our Director Compensation Policy, the total number of shares subject to the stock options underlying the Annual Award granted to a non-employee director as of the date of the annual meeting of stockholders may not exceed 65,000 shares.

(2) Mr. Smith will receive a prorated annual Award based upon his appointment to our Board of Directors in January 2025.

Number of Awards Granted to Employees and Directors . The Awards that an employee, director or consultant may receive under the 2020 Plan cannot be determined in advance because the granting of such Awards is subject to the discretion of the administrator (other than the awards for our non-employee directors described above, which are automatically granted). The following table sets forth the grant date fair value and number of Shares of our stock subject (at grant) to awards granted under the 2020 Plan, the Inducement Plan and the Omniome Plan during our fiscal year 2024, with respect to options and RSUs to the individuals and groups set forth in the table below.

| Name of Individual and Positions, or Group(1)                                               |     | Grant Date Fair Value of Stock Options ($) |         |     | Number of Shares Subject to Stock Options (#) |         |     | Aggregate Grant Date Fair Value of Restricted Stock Units ($) |            |     | Number of Shares Subject to Restricted Stock Units (#) |           |
| Christian O